Ozarelix
- Generic Name
- Ozarelix
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C72H96ClN17O14
- CAS Number
- 295350-45-7
- Unique Ingredient Identifier
- Q1IF8M2YL3
- Background
Ozarelix has been used in trials studying the treatment of Prostate Cancer, Benign Prostatic Hypertrophy, and Benign Prostatic Hyperplasia (BPH).
- Associated Conditions
- -
- Associated Therapies
- -
International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2021-10-05
- Lead Sponsor
- Spectrum Pharmaceuticals, Inc
- Target Recruit Count
- 203
- Registration Number
- NCT01252693
- Locations
- 🇺🇸
Urology Clinics of North Texas, Dallas, Texas, United States
🇺🇸The Urology Center of Colorado, Denver, Colorado, United States
🇺🇸Urology San Antonio Research, San Antonio, Texas, United States
Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-08-28
- Last Posted Date
- 2021-11-22
- Lead Sponsor
- Spectrum Pharmaceuticals, Inc
- Target Recruit Count
- 28
- Registration Number
- NCT00743184
- Locations
- 🇺🇸
California Professional Research, Newport Beach, California, United States
The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate
- First Posted Date
- 2007-01-26
- Last Posted Date
- 2021-10-15
- Lead Sponsor
- Spectrum Pharmaceuticals, Inc
- Target Recruit Count
- 74
- Registration Number
- NCT00427219
- Locations
- 🇺🇸
Jay Young, MD, Laguna Hills, California, United States
🇺🇸Christopher Steidle, MD, Fort Wayne, Indiana, United States
🇺🇸Gregg Eure, MD, Virginia Beach, Virginia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath